Provided by Tiger Trade Technology Pte. Ltd.

4DMEDICAL LTD

3.420
-0.220-6.04%
Volume:5.07M
Turnover:17.83M
Market Cap:2.04B
PE:-10.00
High:3.730
Open:3.680
Low:3.410
Close:3.640
52wk High:7.550
52wk Low:0.755
Shares:597.56M
Float Shares:377.76M
Volume Ratio:1.58
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.342
EPS(LYR):-0.342
ROE:-174.43%
ROA:-15.62%
PB:12.01
PE(LYR):-10.00

Loading ...

Assessing 4DMedical (ASX:4DX) Valuation After Its A$83 Million Follow On Equity Offering

Simply Wall St.
·
Mar 27

4DMedical's Imaging Technology Receives CE Mark Certification; Shares Reach All-Time High

MT Newswires Live
·
Mar 27

ASX Biggest Gainers

MT Newswires Live
·
Mar 27

BRIEF-4DMedical Says CT:VQ Receives CE Mark Certification For Commercial Use In European Union

Reuters
·
Mar 27

BUZZ-Australia's 4DMedical hits record high on EU nod, premium placement

Reuters
·
Mar 27

Stock Track | 4DMedical Ltd Soars 5.10% Intraday on CE Mark Certification for European Union Commercial Use

Stock Track
·
Mar 27

4DMedical Ltd - Ct:Vq Receives Ce Mark Certification for Commercial Use in European Union

THOMSON REUTERS
·
Mar 27

ASX Runners of the Week: Killi, Amplia, NuEnergy and 4D Medical

The West Australian
·
Mar 27

Why is everyone talking about 4DX shares this week?

MotleyFool
·
Mar 26

Forget DroneShield and EOS, this ASX healthcare stock is up 15x in a year!

MotleyFool
·
Mar 26

BUZZ-Australia's 4D Medical hits record high on tech deployment by Mayo Clinic

Reuters
·
Mar 25

Why 4DMedical, Brazilian Rare Earths, Clarity, and Tuas shares are racing higher today

MotleyFool
·
Mar 25

4DMedical Says Mayo Clinic Deploys Cardiothoracic Imaging Product; Shares Reach All-Time Peak

MT Newswires Live
·
Mar 25

Stock Track | 4DMedical Ltd Soars 39.74% on Mayo Clinic Technology Deployment

Stock Track
·
Mar 25

ASX 300 stock rockets 38% on 'landmark moment'

MotleyFool
·
Mar 25

Up over 900%: Is it too late to buy this incredible ASX tech stock?

MotleyFool
·
Mar 18

How Investors May Respond To 4DMedical (ASX:4DX) Losses Surging Despite Flat Half-Year Revenue

Simply Wall St.
·
Mar 10

4DMedical's CT:VQ Product to Contribute 'Meaningful' Revenue in Fiscal Year 2027, Says Jefferies, Shares Up 4%

MT Newswires Live
·
Mar 03

Stock Track | 4DMedical Soars 5.00% Intraday on FDA Approval and US$1.1 Billion Market Potential

Stock Track
·
Mar 02

The Bull Case For 4DMedical (ASX:4DX) Could Change Following CT:VQ Approval And Huge U.S. Market Potential

Simply Wall St.
·
Mar 01